দেশ: অস্ট্রেলিয়া
ভাষা: ইংরেজি
সূত্র: Department of Health (Therapeutic Goods Administration)
indacaterol acetate, Quantity: 173 microgram (Equivalent: indacaterol, Qty 150 microgram); mometasone furoate, Quantity: 160 microgram; glycopyrronium bromide, Quantity: 63 microgram (Equivalent: glycopyrronium, Qty 50 microgram)
Grand Medical Pty Ltd
Capsule, hard
Excipient Ingredients: lactose monohydrate; magnesium stearate
Inhalation
30 capsules + 1 inhaler, 10 capsules + 1 inhaler (sample and commercial packs)
(S4) Prescription Only Medicine
Zimbus Breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
Visual Identification: White to practically white powder in size3 hard hypromellose capsule with green transparent cap & uncoloured transparent body with a black marking surrounded by one black bar on the cap & IGM150-50-160 printed in black above two blackbars on the body; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Registered
2022-07-07